Severely impaired terminal erythroid differentiation as an independent prognostic marker in myelodysplastic syndromes.
Ali AM, Huang Y, Pinheiro RF, Xue F, Hu J, Iverson N, Hoehn D, Coutinho D, Kayani J, Chernak B, Lane J, Hillyer C, Galili N, Jurcic J, Mohandas N, An X, Raza A.
Ali AM, et al. Among authors: hu j.
Blood Adv. 2018 Jun 26;2(12):1393-1402. doi: 10.1182/bloodadvances.2018018440.
Blood Adv. 2018.
PMID: 29903708
Free PMC article.